Found 471 investors
Kielvest Capital
United States
Kielvest Capital was a private company that invested in early-stage technology companies with a focus on laboratory and process instrument companies. Kielvest Capital was invested in companies in the fields of protein processing, biotechnology, web marketing, clinical field trial administration, residential construction, tankless water heaters, carpet recycling and medical prescription administration.
Venture Capital
Kite Pharma
Los Angeles, California, United States
Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications..
Biotechnology
Health Care
Medical
Venture Capital
KLP Enterprises
North Haven, Connecticut, United States
KLP Enterprises is an entrepreneurial investor group that finances biotechnology, clean technology, and software companies.
Venture Capital
KSI Ventures
Russian Federation
KSI Ventures is a seed venture company and accelerator based in Moscow, Russia. The firm seeks to invest in pharmaceutics, medical equipment, cellular and genomic technology, agricultural biotechnology, VR/AR and neurotechnology sectors.
Venture Capital
Kuba Tymula
United States
Mr. Glen Sato served as a Partner at Cooley. He is also an Angel Investor. He is a partner in the Life Sciences and Public Securities practice groups and a member of Cooley Godward Kronish's Business department. He rejoined the Firm in 2006 and is resident in the Palo Alto office. Mr. Sato's practice focuses on corporate transactions, SEC reporting and compliance, disclosure issues, intellectual property licensing and licensing strategy, general corporate counseling, insider trading compliance and working with Boards of Directors and audit committees on various risk and accounting related matters. Together with strong finance capabilities, Sato also has substantial experience in corporate partnering, international and domestic M&A and other heavily negotiated transactions. He has worked closely with underwriters on public and private company acquisitions and led initial public, follow-on and secondary and convertible note offerings. He has also led or been significantly involved in corporate partnering and licensing transactions involving pharmaceutical and biotechnology companies such as Abbott, Bayer, Biogen Idec, Bristol-Myers Squibb, Exelixis, Eli Lilly, Genentech, GlaxoSmithKline, MedImmune, PDL BioPharma, Progenics, Roche, Sankyo and Tanox. Prior to joining the Firm, Mr. Sato served in diverse legal, financial, operational and strategic planning positions where his responsibilities included finance, business development, IS, HR and Facilities. He most recently served as Protein Design Labs' (PDL) Senior Vice President and Chief Financial Officer. He joined PDL from Exelixis, where he served as SVP, Chief Financial Officer and General Counsel for approximately three years. Prior to his time at Exelixis, he served in various legal and strategic planning positions at PDL, including Vice President, Legal and General Counsel. In addition, Mr. Sato worked at NeXT Computer as Associate General Counsel. He was an attorney in Cooley Godward Kronish's Business Department in Palo Alto for two years. Mr. Sato started his career at Jones, Day in Washington, DC. Mr. Sato received his JD and MBA from UCLA in 1987, where he was an Associate Editor of the Law Review. He received a Bachelor's degree in Economics and the College of Social Studies in 1981 from Wesleyan University. Mr. Sato is a member of the State Bar of California and an inactive member of the Washington, DC Bar Association.
Individual/Angel
Kurma Partners
Paris, Ile-de-France, France
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology.
Biotechnology
Financial Services
Health Care
Health Diagnostics
Life Science
Venture Capital
Latartech Holdings
Israel
Latartech Holdings was an Israeli venture capital firm. The firm focused on investing in companies operating in the communications, biotechnology, engineering materials, home products, hardware and technology sectors. It specialized in seed, start-up and growth capital financing.
Venture Capital
Leaders Technology Investment
South Korea
Founded in 1996, Leaders Technology Investment is a private equity firm based in Seoul, South Korea. The firm prefers to invest in companies operating in the computer hardware, pharmaceuticals, and biotechnology sectors.
Private Equity Firm
Le Tarmac
United States
Ms. Irene Chen served as Senior Director and Vice President, Clinical Laboratory Operations at Genomic Health. She is a healthcare professional with extensive experiences in the academic medical centers and biotechnology company settings. Her work experiences include operational, fiscal and human resource management, strategic planning, program management, Laboratory Information System (LIS) and Hospital Information System (HIS) upgrades and implementations, large-scale cross-functional team projects, commercial product launch, business analysis and market assessment, and post-acquisition integration.
Individual/Angel
Liam Ratcliffe
New York, New York
Head of Biotechnology at Access Biotechnology
BioTech
Pharmaceuticals
Therapeutics
Limulus Venture Partners
Newton, Massachusetts, United States
Limulus Venture Partners is a venture capital firm specialized in early stage venture investments in the biotechnology industry.
Venture Capital
Linden Lake Ventures
Bethesda, Maryland, United States
Linden Lake Ventures invest in the next-generation of biotechnology companies.
Venture Capital
Linnaeus Capital Partners
The Netherlands
Founded in 2009, Linnaeus Capital Partners is a private equity fund based in Amsterdam, Netherlands. The firm prefers to invest in aquaculture, fish farming, information technology, biotechnology, communication, and real estate sectors.
Private Equity Firm
Lisa Schechner
New York, New York
Biotechnology Investor at Commodore Capital, LP
BioTech
Pharmaceuticals
Logan Brock
New York, New York
Biotechnology Investor at Commodore Capital, LP
BioTech
Pharmaceuticals
Logos Capital
San Francisco, California, United States
Logos Capital is a fundamental biotechnology-focused investment fund.
Hedge Fund
Private Equity Firm
LongeVC
Lugano, Ticino, Switzerland
LongeVC is an early-stage venture firm that focuses on high-impact investments in biotechnology and healthcare.
Venture Capital
Longitude Capital
Menlo Park, California, United States
Longitude Capital is a California-based venture capital firm that invests in biotechnology and medical technology companies.
Angel Investment
Finance
Venture Capital
Venture Capital
Lotus Pond Investment
China
Founded in 2014, Lotus Pond Investment is one of the corporate investment arms of Tsinghua Holdings Group based in Beijing, China. The firm seeks to make investments in sectors like biotechnology, nanotechnology, B2B product and services, information technology, advanced materials, green technology and other high-tech filed.
Venture Capital
Louisiana Ventures
Las Vegas, Nevada, United States
Based in Las Vegas, Nevada, Louisiana Ventures focuses on agriculture, biotechnology, healthcare, and life sciences companies.
Venture Capital
Showing 261 to
280 of
471 results